+987.9%
MRNA vs MTCH
+27.4%
+960.5%
-34.2%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | MTCH | Excess | Alpha |
|---|---|---|---|---|
| 1D | +13.1% | +4.4% | +8.7% | +9.6% |
| 7D | +20.6% | -4.4% | +25.0% | +24.1% |
| 30D | +27.1% | -0.3% | +27.4% | +26.0% |
| 3M | +353.4% | -2.0% | +355.4% | +345.0% |
| 6M | +446.3% | +6.4% | +439.8% | +411.8% |
| YTD | +776.2% | +27.3% | +748.8% | +673.2% |
| 1Y | +987.9% | +30.3% | +957.6% | +858.3% |
| All | +987.9% | +27.4% | +960.5% | +858.3% |
Cumulative growth
Daily Returns
Daily percentage return beside MTCH.
Daily Out/Under-Performance
Portfolio return minus MTCH return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × MTCH return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded MTCH wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling